Home ›

Publications

Filters: Author is Moreno, V  [Clear All Filters]
Journal Article
Milà N, García M, Binefa G, Borràs JM, Espinàs JA, Moreno V. Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008 . Gaceta sanitaria / S.E.S.P.A.S. 2012;26(3):217-22. Abstract
Dolores Perea M, Castaño-Vinyals G, Altzibar JM, Ascunce N, Moreno V, Tardon A, et al. Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study. . Gaceta sanitaria / S.E.S.P.A.S. 2012. Abstract
Zhang L, Mukherjee B, Ghosh M, Gruber S, Moreno V. Accounting for error due to misclassification of exposures in case-control studies of gene-environment interaction. Statistics in medicine. 2008;27(15):2756-83.
Zamora-Ros R, Not C, Guinó E, Luján-Barroso L, García RM, Biondo S, et al. Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study). Cancer causes & control : CCC. 2012. Abstract
Boonstra PS, Mukherjee B, Taylor JM, Nilbert M, Moreno V, Gruber SB. Bayesian modeling for genetic anticipation in presence of mutational heterogeneity: a case study in Lynch syndrome. Biometrics. 2011;67(4):1627-37. Abstract
Solé X, Bonifaci N, López-Bigas N, Berenguer A, Hernández P, Reina O, et al. Biological convergence of cancer signatures. PloS one. 2009;4(2):e4544.
Bonifaci N, Berenguer A, Díez J, Reina O, Medina I, Dopazo J, et al. Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes. BMC medical genomics. 2008;1:62.
Fernandez-Rozadilla C, Palles C, Carvajal-Carmona L, Peterlongo P, Nici C, Veneroni S, et al. BMP2/BMP4 colorectal cancer susceptibility loci in Northern and Southern European populations. Carcinogenesis. 2012. Abstract
Abulí A, Fernández-Rozadilla C, Alonso-Espinaco V, Muñoz J, Gonzalo V, Bessa X, et al. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins. BMC cancer. 2011;11:339. Abstract
de Oca J, Azuara D, Sanchez-Santos R, Navarro M, Capella G, Moreno V, et al. Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer. International journal of colorectal disease. 2008;23(1):21-7.
Valls J, Grau M, Solé X, Hernández P, Montaner D, Dopazo J, et al. CLEAR-test: combining inference for differential expression and variability in microarray data analysis. Journal of biomedical informatics. 2008;41(1):33-45.
Sanz-Pamplona R, Berenguer A, Cordero D, Riccadonna S, Solé X, Crous-Bou M, et al. Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review. PloS one. 2012;7(11):e48877. Abstract
Santos C, López-Doriga A, Navarro M, Mateo J, Biondo S, Martínez Villacampa M, et al. Clinicopathological risk factors of Stage II colon cancer: results of a prospective study. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2013;15(4):414-22. Abstract
Houlston RS, members of CO, Moreno V. COGENT (COlorectal cancer GENeTics) revisited. Mutagenesis. 2012;27(2):143-51. Abstract
Tomlinson IP, Dunlop M, Campbell H, Zanke B, Gallinger S, Hudson T, et al. COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. British journal of cancer. 2010;102(2):447-54. Abstract
Fernandez-Rozadilla C, Cazier JB, Tomlinson IP, Carvajal-Carmona LG, Palles C, Lamas MJ, et al. A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12. BMC genomics. 2013;14:55. Abstract
Tian S, Simon I, Moreno V, Roepman P, Tabernero J, Snel M, et al. A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction. Gut. 2012. Abstract
Stevens KN, Hakonarson H, Kim CE, Doevendans PA, Koeleman BP, Mital S, et al. Common variation in ISL1 confers genetic susceptibility for human congenital heart disease. PloS one. 2010;5(5):e10855. Abstract
Campa D, Martino A, Sainz J, Buda G, Jamroziak K, Weinhold N, et al. Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. British journal of haematology. 2012;157(3):331-8. Abstract
Villanueva CM, Castaño-Vinyals G, Moreno V, Carrasco-Turigas G, Aragonés N, Boldo E, et al. Concentrations and correlations of disinfection by-products in municipal drinking water from an exposure assessment perspective. Environmental research. 2012;114:1-11. Abstract
Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, et al. A DNA methylation fingerprint of 1628 human samples. Genome research. 2012;22(2):407-19. Abstract
Bonifaci N, Palafox M, Pellegrini P, Osorio A, Benítez J, Peterlongo P, et al. Evidence for a link between TNFRSF11A and risk of breast cancer. Breast cancer research and treatment. 2011;129(3):947-54. Abstract
Saunders IW, Ross J, Macrae F, Young GP, Blanco I, Brohede J, et al. Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families. European journal of human genetics : EJHG. 2012;20(1):91-6. Abstract
Martrat G, Maxwell CA, Tominaga E, Porta M, Bonifaci N, Gomez-Baldo L, et al. Exploring the link between MORF4L1 and risk of breast cancer. Breast cancer research : BCR. 2011;13(2):R40. Abstract
Sanz-Pamplona R, Aragüés R, Driouch K, Martín B, Oliva B, Gil M, et al. Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors. The American journal of pathology. 2011;179(2):564-79. Abstract